Skip to main content

Tower Research Capital LLC (TRC)

Position in GANX — Gain Therapeutics, Inc.

CIK 1533421 NEW YORK, NY

Position in GANX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$16,891
+$6,210 QoQ
Shares Held
8,321
+51.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 49 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GANX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. GANX ranks #263 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GANX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,891 8,321
2026-03-31 $10,681 5,506
2025-12-31 $22,085 6,859
2025-09-30 $3,653 2,064
2025-06-30 $1,701 945
2025-03-31 $4,645 2,432
2024-09-30 $8,618 4,842
2024-06-30 $2,213 1,729
2024-03-31 $17,462 4,632
2023-12-31 $15,971 4,892
2023-09-30 $9,413 2,870
2023-06-30 $19,473 4,347
2023-03-31 $32,987 6,844
2022-12-31 $22,385 7,152
2022-09-30 $17,150 5,261
2022-06-30 $2,576 716
2022-03-31 $2,425 593
2021-12-31 $6,353 1,170
2021-09-30 $4,131 555
2021-06-30 $720 72